Platinum-based chemotherapeutic agent cisplatin was rarely reported to cause T2DM and hyperglycaemic crisis; however, fewer cases are reported compared to immune checkpoint inhibitors, and these cases were not insulin-dependent. This evidence concerns the gene INS and type 2 diabetes mellitus.